scholarly article | Q13442814 |
P2093 | author name string | B. P. Kennedy | |
H. E. Claesson | |||
P. K. Larsson | |||
P2860 | cites work | Purification, properties, sequencing, and cloning of a lipoprotein-associated, serine-dependent phospholipase involved in the oxidative modification of low-density lipoproteins | Q24309062 |
bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death | Q24312157 | ||
Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? | Q28249671 | ||
Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes | Q28289034 | ||
A novel cytosolic calcium-independent phospholipase A2 contains eight ankyrin motifs | Q28306525 | ||
Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death | Q28507741 | ||
Pancreatic islets express a Ca2+-independent phospholipase A2 enzyme that contains a repeated structural motif homologous to the integral membrane protein binding domain of ankyrin | Q28577938 | ||
Cytosolic phospholipase A2 | Q28609569 | ||
Inhibition of calcium-independent phospholipase A2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages | Q33989590 | ||
Leukotrienes: Mediators of Immediate Hypersensitivity Reactions and Inflammation | Q34254403 | ||
Alternative splicing of RNA transcripts encoded by the murine p105 NF-kappa B gene generates I kappa B gamma isoforms with different inhibitory activities | Q35230057 | ||
NF-kappa B and related proteins: Rel/dorsal homologies meet ankyrin-like repeats | Q35875812 | ||
On the expression and regulation of 5-lipoxygenase in human lymphocytes. | Q36959306 | ||
Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex | Q38333812 | ||
Mammalian calcium-independent phospholipase A2. | Q40375569 | ||
The I kappa B proteins: members of a multifunctional family | Q40721710 | ||
The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors | Q40773951 | ||
The growing phospholipase A2 superfamily of signal transduction enzymes | Q41341078 | ||
Function and inhibition of intracellular calcium-independent phospholipase A2. | Q41509814 | ||
Human B lymphocytes possess 5-lipoxygenase activity and convert arachidonic acid to leukotriene B4. | Q41674889 | ||
Identity between the Ca2+-independent phospholipase A2 enzymes from P388D1 macrophages and Chinese hamster ovary cells | Q42436218 | ||
Human myocardial cytosolic Ca(2+)-independent phospholipase A2 is modulated by ATP. Concordant ATP-induced alterations in enzyme kinetics and mechanism-based inhibition | Q42792277 | ||
Identification and purification of calcium-independent phospholipase A2 from bovine brain cytosol | Q44045296 | ||
Paired Epstein-Barr virus (EBV)-negative and EBV-converted Burkitt lymphoma lines: stimulatory capacity in allogeneic mixed lymphocyte cultures | Q45842380 | ||
I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family | Q46153930 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | phospholipase A2 activity | Q14905446 |
phospholipase A2 group VI | Q21126834 | ||
P304 | page(s) | 207–214 | |
P577 | publication date | 1998-01-02 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Multiple splice variants of the human calcium-independent phospholipase A2 and their effect on enzyme activity | |
P478 | volume | 273 |
Q37963183 | A PLA1-2 punch regulates the Golgi complex |
Q39776402 | A bromoenol lactone suicide substrate inactivates group VIA phospholipase A2 by generating a diffusible bromomethyl keto acid that alkylates cysteine thiols |
Q22254197 | A novel intracellular membrane-bound calcium-independent phospholipase A(2) |
Q44556049 | A requirement for calcium-independent phospholipase A2 in thrombin-induced arachidonic acid release and growth in vascular smooth muscle cells |
Q30497505 | ADP Ribosylation Factors 1 and 4 and Group VIA Phospholipase A2Regulate Morphology and Intraorganellar Traffic in the Endoplasmic Reticulum–Golgi Intermediate Compartment |
Q50521928 | Activation by P2X7 agonists of two phospholipases A2 (PLA2) in ductal cells of rat submandibular gland. Coupling of the calcium-independent PLA2 with kallikrein secretion. |
Q34782165 | Activation of group VI phospholipase A2 isoforms in cardiac endothelial cells |
Q36512269 | Age-related changes in bone morphology are accelerated in group VIA phospholipase A2 (iPLA2beta)-null mice |
Q38722497 | Analyses of Calcium-Independent Phospholipase A2beta (iPLA2β) in Biological Systems |
Q35423551 | Analysis of two major intracellular phospholipases A(2) (PLA(2)) in mast cells reveals crucial contribution of cytosolic PLA(2)α, not Ca(2+)-independent PLA(2)β, to lipid mobilization in proximal mast cells and distal fibroblasts |
Q34206288 | Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. |
Q33595339 | Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. |
Q50293881 | CL is hydrolyzed to MLCL by PLA2G6 (IM) |
Q44209209 | Ca2+-independent phospholipase A2 is required for agonist-induced Ca2+ sensitization of contraction in vascular smooth muscle |
Q34083751 | Calcium-independent phospholipase A(2): structure and function. |
Q33699583 | Calcium-independent phospholipase A2 in rabbit ventricular myocytes |
Q35994344 | Calcium-independent phospholipases A2 and their roles in biological processes and diseases. |
Q37199186 | Calcium-independent phospholipases in the heart: mediators of cellular signaling, bioenergetics, and ischemia-induced electrophysiologic dysfunction |
Q44905130 | Cell cycle dependence of group VIA calcium-independent phospholipase A2 activity |
Q28248355 | Characterization of the human patatin-like phospholipase family |
Q37130148 | Cholinergic and glutamatergic alterations beginning at the early stages of Alzheimer disease: participation of the phospholipase A2 enzyme |
Q35763978 | Clearance of apoptotic cells: getting rid of the corpses. |
Q28315639 | Clinical and genetic delineation of neurodegeneration with brain iron accumulation |
Q93103175 | Combined targeted Omic and Functional Assays Identify Phospholipases A₂ that Regulate Docking/Priming in Calcium-Triggered Exocytosis |
Q47877765 | Complex transcriptional and translational regulation of iPLAgamma resulting in multiple gene products containing dual competing sites for mitochondrial or peroxisomal localization |
Q48848896 | Conditioning training and retrieval increase phospholipase A(2) activity in the cerebral cortex of rats. |
Q30785490 | Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships |
Q40287484 | Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides |
Q34049279 | Disruption of G1-phase phospholipid turnover by inhibition of Ca2+-independent phospholipase A2 induces a p53-dependent cell-cycle arrest in G1 phase |
Q35868876 | Disruption of Golgi morphology and altered protein glycosylation in PLA2G6-associated neurodegeneration |
Q35793998 | Distinct phospholipase A2 enzymes regulate prostaglandin E2 and F2alpha production by bovine endometrial epithelial cells |
Q39334780 | Diverse regulation of retinal pigment epithelium phagocytosis of photoreceptor outer segments by calcium-independent phospholipase A₂, group VIA and secretory phospholipase A₂, group IB. |
Q34212477 | Diversity and regulatory functions of mammalian secretory phospholipase A2s. |
Q42037362 | Effects of biological oxidants on the catalytic activity and structure of group VIA phospholipase A2 |
Q36302173 | Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells |
Q73626672 | Electrospray ionization/mass spectrometric analyses of human promonocytic U937 cell glycerolipids and evidence that differentiation is associated with membrane lipid composition changes that facilitate phospholipase A2 activation |
Q28201886 | Enzymatic properties of human cytosolic phospholipase A(2)gamma |
Q37462762 | Establishment of an improved mouse model for infantile neuroaxonal dystrophy that shows early disease onset and bears a point mutation in Pla2g6. |
Q48021878 | Expression profile and structural divergence of novel human annexin 31. |
Q28248992 | Fcgamma RI-triggered generation of arachidonic acid and eicosanoids requires iPLA2 but not cPLA2 in human monocytic cells |
Q40978833 | Functional coupling between various phospholipase A2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways |
Q92042954 | Furosine, a Maillard Reaction Product, Triggers Necroptosis in Hepatocytes by Regulating the RIPK1/RIPK3/MLKL Pathway |
Q33886495 | Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death |
Q38532119 | Group VIA phospholipase A2 mediates enhanced macrophage migration in diabetes mellitus by increasing expression of nicotinamide adenine dinucleotide phosphate oxidase 4. |
Q39877154 | HL-1 mouse cardiomyocyte injury and death after simulated ischemia and reperfusion: roles of pH, Ca2+-independent phospholipase A2, and Na+/H+ exchange |
Q33238930 | Highly selective hydrolysis of fatty acyl-CoAs by calcium-independent phospholipase A2beta. Enzyme autoacylation and acyl-CoA-mediated reversal of calmodulin inhibition of phospholipase A2 activity |
Q28139679 | Human Pancreatic Islets Express mRNA Species Encoding Two Distinct Catalytically Active Isoforms of Group VI Phospholipase A2 (iPLA2) [etc.] |
Q74241715 | Human calcium-independent phospholipase A2 mediates lymphocyte proliferation |
Q36511361 | Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's disease |
Q44014781 | Implication of three isoforms of PLA(2) in human T-cell proliferation. |
Q64899416 | Infantile neuroaxonal dystrophy caused by PLA2G6 gene mutation in a Chinese patient: A case report. |
Q28581430 | Inhibition of calcium-independent phospholipase A2 activity in rat hippocampus impairs acquisition of short- and long-term memory |
Q53317312 | Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein. |
Q28534839 | Insertion of the Ca²⁺-independent phospholipase A₂ into a phospholipid bilayer via coarse-grained and atomistic molecular dynamics simulations |
Q36097167 | Insulin secretory responses and phospholipid composition of pancreatic islets from mice that do not express Group VIA phospholipase A2 and effects of metabolic stress on glucose homeostasis. |
Q34555536 | Interferon gamma-induced gene expression of the novel secretory phospholipase A2 type IID in human monocyte-derived macrophages is inhibited by lipopolysaccharide |
Q35641753 | Islet complex lipids: involvement in the actions of group VIA calcium-independent phospholipase A(2) in beta-cells |
Q47133692 | Lipoquality control by phospholipase A2 enzymes |
Q37358176 | Localizing the membrane binding region of Group VIA Ca2+-independent phospholipase A2 using peptide amide hydrogen/deuterium exchange mass spectrometry |
Q33681195 | Mammalian lysophospholipases. |
Q34198990 | Mammalian phospholipases A(2): mediators of inflammation, proliferation and apoptosis |
Q36945608 | Membrane and inhibitor interactions of intracellular phospholipases A2. |
Q49248448 | Mutations in the Drosophila homolog of human PLA2G6 give rise to age-dependent loss of psychomotor activity and neurodegeneration |
Q21129274 | Neurodegeneration with brain iron accumulation: update on pathogenic mechanisms |
Q26821831 | Neuronal phospholipid deacylation is essential for axonal and synaptic integrity |
Q33695148 | New developments in phospholipase A2. |
Q92093905 | Novel allelic variation in the Phospholipase D alpha1 gene (OsPLDα1) of wild Oryza species implies to its low expression in rice bran |
Q28592582 | On the diversity of secreted phospholipases A(2). Cloning, tissue distribution, and functional expression of two novel mouse group II enzymes |
Q77317915 | On the expression of cytosolic calcium-independent phospholipase A2 (88kDa) in immature and mature myeloid cells and its role in leukotriene synthesis in human granulocytes |
Q50293818 | PC is hydrolyzed to 1-acyl LPC by PLA2[5] |
Q50293780 | PE is hydrolyzed to 1-acyl LPE by PLA2[2] |
Q35221441 | PLA2G6 mutation underlies infantile neuroaxonal dystrophy |
Q34568479 | PLA2G6, encoding a phospholipase A2, is mutated in neurodegenerative disorders with high brain iron |
Q33722781 | PLA2G6-associated neurodegeneration (PLAN): further expansion of the clinical, radiological and mutation spectrum associated with infantile and atypical childhood-onset disease |
Q33195299 | Pancreatic islets and insulinoma cells express a novel isoform of group VIA phospholipase A2 (iPLA2 beta) that participates in glucose-stimulated insulin secretion and is not produced by alternate splicing of the iPLA2 beta transcript |
Q34852161 | Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease |
Q38830281 | Phospholipase A2 as a Molecular Determinant of Store-Operated Calcium Entry. |
Q28297979 | Phospholipase A2 biochemistry |
Q28609770 | Phospholipase A2 enzymes |
Q26997377 | Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention |
Q35202874 | Phospholipase A2 expression in tumours: a target for therapeutic intervention? |
Q37658843 | Phospholipase A2 inhibitors as potential therapeutic agents for the treatment of inflammatory diseases. |
Q33833653 | Potent and selective fluoroketone inhibitors of group VIA calcium-independent phospholipase A2. |
Q34004751 | Purification and characterization of a cytosolic Ca(2+)-independent phospholipase A(2) from bovine brain |
Q35042360 | Pyrimidinoceptor potentiation of macrophage PGE(2) release involved in the induction of nitric oxide synthase |
Q41687052 | Regional distribution, ontogeny, purification, and characterization of the Ca2+-independent phospholipase A2 from rat brain |
Q44862176 | Regulation of phosphatidylcholine homeostasis by calcium-independent phospholipase A2. |
Q26995761 | Regulation of the Golgi complex by phospholipid remodeling enzymes |
Q48387193 | Requirement of hippocampal phospholipase A2 activity for long-term memory retrieval in rats |
Q36800670 | Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories. |
Q44094421 | Role of an endoplasmic reticulum Ca(2+)-independent phospholipase A(2) in oxidant-induced renal cell death |
Q46825749 | Role of calcium-independent phospholipase A2 in complement-mediated glomerular epithelial cell injury |
Q40611926 | Role of secretory and cytosolic phospholipase A(2) enzymes in lysophosphatidylcholine-stimulated monocyte arachidonic acid release |
Q43001896 | Roles of various phospholipases A2 in providing lysophospholipid acceptors for fatty acid phospholipid incorporation and remodelling |
Q37240112 | Skeletal muscle group VIA phospholipase A2 (iPLA2beta): expression and role in fatty acid oxidation |
Q43719219 | Studies of phospholipid metabolism, proliferation, and secretion of stably transfected insulinoma cells that overexpress group VIA phospholipase A2. |
Q42467888 | Study on the activation of phospholipases A2 by purinergic agonists in rat submandibular ductal cells. |
Q28609761 | The expanding superfamily of phospholipase A(2) enzymes: classification and characterization |
Q28295918 | The expression and function of a group VIA calcium-independent phospholipase A2 (iPLA2beta) in beta-cells |
Q28144429 | The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene |
Q34348429 | The molecular biology of the group VIA Ca2+-independent phospholipase A2. |
Q31080755 | The role of phospholipase A2 in neuronal homeostasis and memory formation: implications for the pathogenesis of Alzheimer's disease |
Q50282174 | The structure of iPLA2β reveals dimeric active sites and suggests mechanisms of regulation and localization |
Q58609392 | iPLAβ and its role in male fertility, neurological disorders, metabolic disorders, and inflammation |
Search more.